ERBB2 and breast cancer: Recent gene expression studies using DNA microarrays have revealed the prognostic implication of breast cancer intrinsic subtypes, including the basal-like, HER2+/ER-, and two types of ER+ tumors: luminal A and luminal B subtypes [10,11].